These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27930979)

  • 1. Hp91 immunoadjuvant: An HMGB1-derived peptide for development of therapeutic HPV vaccines.
    Talebi S; Bolhassani A; Sadat SM; Vahabpour R; Agi E; Shahbazi S
    Biomed Pharmacother; 2017 Jan; 85():148-154. PubMed ID: 27930979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-Stimulating Peptide Derived from HMGB1 is More Effective Than the N-Terminal Domain of Gp96 as an Endogenous Adjuvant for Improvement of Protein Vaccines.
    Talebi S; Bolhassani A; Azad TM; Arashkia A; Modaresi MH
    Protein Pept Lett; 2017; 24(3):190-196. PubMed ID: 28000571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of HCV Therapeutic Vaccines Using Hp91 Peptide and Small Heat Shock Protein 20 as an Adjuvant.
    Basirnejad M; Bolhassani A
    Protein Pept Lett; 2018; 25(10):924-932. PubMed ID: 30255740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women.
    Ramezani A; Aghakhani A; Soleymani S; Bavand A; Bolhassani A
    BMC Infect Dis; 2019 Feb; 19(1):142. PubMed ID: 30755156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory effects of IP-10 chemokine along with PEI600-Tat delivery system in DNA vaccination against HPV infections.
    Mohit E; Bolhassani A; Zahedifard F; Seyed N; Eslamifar A; Taghikhani M; Samimi-Rad K; Rafati S
    Mol Immunol; 2013 Jan; 53(1-2):149-60. PubMed ID: 22926003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small heat shock protein 27: An effective adjuvant for enhancement of HIV-1 Nef antigen-specific immunity.
    Milani A; Bolhassani A; Shahbazi S; Motevalli F; Sadat SM; Soleymani S
    Immunol Lett; 2017 Nov; 191():16-22. PubMed ID: 28917624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of the HMGB1-derived immunostimulatory peptide Hp91 resides in the helical C-terminal portion and is enhanced by dimerization.
    Saenz R; Messmer B; Futalan D; Tor Y; Larsson M; Daniels G; Esener S; Messmer D
    Mol Immunol; 2014 Feb; 57(2):191-9. PubMed ID: 24172222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model.
    Daemi A; Bolhassani A; Rafati S; Zahedifard F; Hosseinzadeh S; Doustdari F
    Immunol Lett; 2012 Dec; 148(2):117-25. PubMed ID: 23085605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies.
    Bolhassani A; Zahedifard F; Taghikhani M; Rafati S
    Vaccine; 2008 Jun; 26(26):3362-70. PubMed ID: 18471945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel self-assembled nanoparticle vaccine with HIV-1 Tat₄₉₋₅₇/HPV16 E7₄₉₋₅₇ fusion peptide and GM-CSF DNA elicits potent and prolonged CD8⁺ T cell-dependent anti-tumor immunity in mice.
    Tang J; Yin R; Tian Y; Huang Z; Shi J; Fu X; Wang L; Wu Y; Hao F; Ni B
    Vaccine; 2012 Feb; 30(6):1071-82. PubMed ID: 22178528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel, broad spectrum therapeutic HPV vaccine targeting the E7 proteins of HPV16, 18, 31, 45 and 52 that elicits potent E7-specific CD8T cell immunity and regression of large, established, E7-expressing TC-1 tumors.
    Wick DA; Webb JR
    Vaccine; 2011 Oct; 29(44):7857-66. PubMed ID: 21816200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of NT-gp96 as an adjuvant for increasing HPV16 E7-specific immunity in C57BL /6 mouse model.
    Mohit E; Bolhassani A; Zahedifard F; Taslimi Y; Rafati S
    Scand J Immunol; 2012 Jan; 75(1):27-37. PubMed ID: 21916914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with human papillomavirus type 16-derived peptides using a tattoo device.
    Pokorná D; Poláková I; Kindlová M; Dusková M; Ludvíková V; Gabriel P; Kutinová L; Müller M; Smahel M
    Vaccine; 2009 Jun; 27(27):3519-29. PubMed ID: 19464530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSP70 modified response against HPV based tumor.
    Farzanehpour M; Soleimanjahi H; Hassan ZM; Amanzadeh A; Ghaemi A; Fazeli M
    Eur Rev Med Pharmacol Sci; 2013 Jan; 17(2):228-34. PubMed ID: 23377813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model.
    Salehi M; Taheri T; Mohit E; Zahedifard F; Seyed N; Taslimi Y; Sattari M; Bolhassani A; Rafati S
    Immunotherapy; 2012 Nov; 4(11):1107-20. PubMed ID: 23194361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant.
    Saenz R; Futalan D; Leutenez L; Eekhout F; Fecteau JF; Sundelius S; Sundqvist S; Larsson M; Hayashi T; Minev B; Carson D; Esener S; Messmer B; Messmer D
    J Transl Med; 2014 Aug; 12():211. PubMed ID: 25123824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccine encoding HPV-16 E7 with mutation in L-Y-C-Y-E pRb-binding motif induces potent anti-tumor responses in mice.
    Bahrami AA; Ghaemi A; Tabarraei A; Sajadian A; Gorji A; Soleimanjahi H
    J Virol Methods; 2014 Sep; 206():12-8. PubMed ID: 24880067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MPG-based nanoparticle: An efficient delivery system for enhancing the potency of DNA vaccine expressing HPV16E7.
    Saleh T; Bolhassani A; Shojaosadati SA; Aghasadeghi MR
    Vaccine; 2015 Jun; 33(28):3164-70. PubMed ID: 26001433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
    Seo SH; Jin HT; Park SH; Youn JI; Sung YC
    Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein vaccination with HPV16 E7/Pep-1 nanoparticles elicits a protective T-helper cell-mediated immune response.
    Mardani G; Bolhassani A; Agi E; Shahbazi S; Mehdi Sadat S
    IUBMB Life; 2016 Jun; 68(6):459-67. PubMed ID: 27094221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.